FDA approves Boehringer's lung disease drug

FDA approves Boehringer's lung disease drug

9:49 AM, 7th September 2019
Boehringer Ingelheim logo

MARYLAND, US: The US Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim's Ofev capsules for a rare lung disorder.

The drug is first FDA-approved treatment for this condition, the FDA said in a statement.

The drug is aimed at slowing the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis, an autoimmune condition.

Ofev was originally approved in 2014 for adult patients with idiopathic pulmonary fibrosis, which is another interstitial lung condition.

Source: Reuters

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


DSM appoints new president for DSM Engineering Plastics

SINGAPORE: Royal DSM has appointed Shruti Singhal as President DSM Engineering Plastics, effective 1 October 2019. Shruti, a US national, joined DSM ...

Read more
Clariant’s new CFA masterbatches cut plastics content in packaging by 10%

MUTTENZ, SWITZERLAND: Packaging manufacturers and brand owners trying to reach sustainability goals and reduce costs are expressing keen interest in t ...

Read more
Evonik invests in Chinese medical implants 3D-printing start-up

ESSEN, GERMANY/SHANGHAI, CHINA: Evonik Venture Capital has invested in a 3D-printing start-up in China that makes implants for neuro and spine surgery ...

Read more
Sumitomo Dainippon Pharma to invest $3 bn in Swiss Roivant

TOKYO, JAPAN: Sumitomo Dainippon Pharma Co will pay $3 billion for a 10% stake in Swiss drugmaker Roivant Sciences Ltd and interests in five of its bi ...

Read more
Hempel launches new coating system - Hempaguard MaX

LYNGBY, DENMARK: Hempel has launched an innovative new fouling defence system – Hempaguard MaX. This unique three-coat system provides vessels w ...

Read more
LyondellBasell, Bora sign MoU for China expansion

ROTTERDAM, NETHERLANDS/HONG KONG, CHINA: LyondellBasell has signed a memorandum of understanding (MoU) to expand in China through a Joint Venture (JV) ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X